Elevance Health, Inc. ELV
Institutional shares held
201 Million
1.53M
calls
1.37M
puts
Total value of holdings
$85.4B
$648M
calls
$583M
puts
Market Cap
$102B
240,000,992
Shares Out.
Institutional ownership
83.79%
# of Institutions
1,832
We take great care to ensure that the data presented and summarized in this overview for Elevance Health, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding ELV
View all-
Vanguard Group Inc Valley Forge, PA21.5MShares$9.12 Billion0.14% of portfolio
-
Black Rock Inc. New York, NY20.7MShares$8.79 Billion0.26% of portfolio
-
State Street Corp Boston, MA10.7MShares$4.53 Billion0.16% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD10.6MShares$4.51 Billion0.45% of portfolio
-
Geode Capital Management, LLC Boston, MA4.96MShares$2.11 Billion0.15% of portfolio
-
Sanders Capital, LLC West Palm Beach, FL4.69MShares$1.99 Billion2.55% of portfolio
-
Capital International Investors Los Angeles, CA3.88MShares$1.65 Billion0.28% of portfolio
-
First Eagle Investment Management, LLC3.23MShares$1.37 Billion2.69% of portfolio
-
Norges Bank Oslo, Q83.08MShares$1.31 Billion0.15% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI2.88MShares$1.22 Billion1.7% of portfolio
Latest Institutional Activity in ELV
Top Purchases
Top Sells
About ELV
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
Insider Transactions at ELV
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|
Mar 10
2025
|
Ronald W Penczek CAO & Controller |
SELL
Open market or private sale
|
Direct |
443
-19.35%
|
$183,845
$415.13 P/Share
|
|
Mar 05
2025
|
Charles Morgan Kendrick Jr EVP & President, Commercial |
SELL
Open market or private sale
|
Direct |
3,504
-25.73%
|
$1,387,584
$396.3 P/Share
|
|
Mar 03
2025
|
Charles Morgan Kendrick Jr EVP & President, Commercial |
BUY
Grant, award, or other acquisition
|
Direct |
6,531
+21.78%
|
-
|
|
Mar 03
2025
|
Charles Morgan Kendrick Jr EVP & President, Commercial |
SELL
Payment of exercise price or tax liability
|
Direct |
2,221
-23.86%
|
$877,295
$395.5 P/Share
|
|
Mar 03
2025
|
Ronald W Penczek CAO & Controller |
BUY
Grant, award, or other acquisition
|
Direct |
706
+14.38%
|
-
|
|
Mar 03
2025
|
Ronald W Penczek CAO & Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
198
-11.11%
|
$78,210
$395.5 P/Share
|
|
Mar 03
2025
|
Felicia F Norwood EVP & President,Gov Health Ben |
BUY
Grant, award, or other acquisition
|
Direct |
7,248
+10.76%
|
-
|
|
Mar 03
2025
|
Felicia F Norwood EVP & President,Gov Health Ben |
SELL
Payment of exercise price or tax liability
|
Direct |
2,613
-9.57%
|
$1,032,135
$395.5 P/Share
|
|
Mar 03
2025
|
Ratnakar Lavu EVP, Chief Digital & Info Off |
BUY
Grant, award, or other acquisition
|
Direct |
2,339
+32.84%
|
-
|
|
Mar 03
2025
|
Ratnakar Lavu EVP, Chief Digital & Info Off |
SELL
Payment of exercise price or tax liability
|
Direct |
312
-11.32%
|
$123,240
$395.5 P/Share
|
|
Mar 03
2025
|
Peter D Haytaian EVP & Pres Carelon & CarelonRx |
BUY
Grant, award, or other acquisition
|
Direct |
7,248
+13.08%
|
-
|
|
Mar 03
2025
|
Peter D Haytaian EVP & Pres Carelon & CarelonRx |
SELL
Payment of exercise price or tax liability
|
Direct |
2,281
-10.84%
|
$900,995
$395.5 P/Share
|
|
Mar 03
2025
|
Gail Boudreaux President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
26,207
+8.79%
|
-
|
|
Mar 03
2025
|
Gail Boudreaux President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,396
-8.2%
|
$4,106,420
$395.5 P/Share
|
|
Mar 03
2025
|
Mark Kaye EVP & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
3,604
+13.27%
|
-
|
|
Mar 03
2025
|
Mark Kaye EVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
270
-1.33%
|
$106,650
$395.5 P/Share
|
|
Jan 03
2025
|
Blair Williams Todt EVP, CLO & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
398
-2.48%
|
$147,658
$371.56 P/Share
|
|
Nov 01
2024
|
Peter D Haytaian EVP & Pres Carelon & CarelonRx |
BUY
Grant, award, or other acquisition
|
Direct |
3,799
+15.3%
|
-
|
|
Nov 01
2024
|
Peter D Haytaian EVP & Pres Carelon & CarelonRx |
SELL
Payment of exercise price or tax liability
|
Direct |
1,649
-8.73%
|
$682,686
$414.01 P/Share
|
|
Nov 01
2024
|
Charles Morgan Kendrick Jr EVP & President, Commercial |
BUY
Grant, award, or other acquisition
|
Direct |
1,710
+15.55%
|
-
|
Last 12 Months Summary
Buy / Acquisition
70.8K
Shares
From
18
Insiders
| Grant, award, or other acquisition | 63.3K shares |
|---|---|
| Exercise of conversion of derivative security | 7.52K shares |
Sell / Disposition
90.7K
Shares
From
14
Insiders
| Payment of exercise price or tax liability | 24K shares |
|---|---|
| Open market or private sale | 66.7K shares |